Carregant...
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
Treatment of advanced hepatocellular carcinoma remains unsatisfying and so far only prognostic biomarkers like α-fetoprotein have been established. No clear predictive biomarker is currently available for standard of care therapies, including targeted therapies like sorafenib. Novel therapeutic opti...
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148424/ https://ncbi.nlm.nih.gov/pubmed/30254402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i35.3974 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|